{"name":"SHANDONG","slug":"shandong","ticker":"","exchange":"","domain":"shandong.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":33,"colorKey":"cardiovascular","drugs":[{"name":"Esomeprazole sodium for injection","genericName":"Esomeprazole sodium for injection","slug":"esomeprazole-sodium-for-injection","indication":"Gastroesophageal reflux disease","status":"phase_2"},{"name":"an extract of Cimicifuga Foetida L.","genericName":"an extract of Cimicifuga Foetida L.","slug":"an-extract-of-cimicifuga-foetida-l","indication":"Menopausal symptoms (hot flashes, night sweats, mood disturbances)","status":"marketed"},{"name":"mLDG","genericName":"mLDG","slug":"mldg","indication":"Other","status":"phase_2"},{"name":"BA1106","genericName":"BA1106","slug":"ba1106","indication":"Other","status":"phase_1"},{"name":"CM336 Injection","genericName":"CM336 Injection","slug":"cm336-injection","indication":"Other","status":"phase_3"},{"name":"Caspogunfin","genericName":"Caspogunfin","slug":"caspogunfin","indication":"Other","status":"phase_2"},{"name":"Fluvustat","genericName":"Fluvustat","slug":"fluvustat","indication":"Other","status":"phase_1"},{"name":"Glycyrrhetinic Acid","genericName":"Glycyrrhetinic Acid","slug":"glycyrrhetinic-acid","indication":"Other","status":"marketed"},{"name":"Gushen Antai Pill","genericName":"Gushen Antai Pill","slug":"gushen-antai-pill","indication":"Threatened abortion and recurrent miscarriage","status":"marketed"},{"name":"HRS-1780 Tablets","genericName":"HRS-1780 Tablets","slug":"hrs-1780-tablets","indication":"Other","status":"phase_3"},{"name":"HRS-1893 Tablets","genericName":"HRS-1893 Tablets","slug":"hrs-1893-tablets","indication":"Other","status":"phase_3"},{"name":"HRS-7085","genericName":"HRS-7085","slug":"hrs-7085","indication":"Other","status":"phase_2"},{"name":"HRS-7535 Tablets","genericName":"HRS-7535 Tablets","slug":"hrs-7535-tablets","indication":"Other","status":"phase_3"},{"name":"HRS-7535 tablet","genericName":"HRS-7535 tablet","slug":"hrs-7535-tablet","indication":"Other","status":"phase_3"},{"name":"HRS-8080 Tablets","genericName":"HRS-8080 Tablets","slug":"hrs-8080-tablets","indication":"Other","status":"phase_3"},{"name":"Henagliflozin 10mg","genericName":"Henagliflozin 10mg","slug":"henagliflozin-10mg","indication":"Other","status":"marketed"},{"name":"Huazhi Rougan Granule Placebo granule","genericName":"Huazhi Rougan Granule Placebo granule","slug":"huazhi-rougan-granule-placebo-granule","indication":"Clinical trial control comparator (non-therapeutic use)","status":"marketed"},{"name":"LY01015","genericName":"LY01015","slug":"ly01015","indication":"Other","status":"phase_3"},{"name":"Laxative Polyethylene Glycol","genericName":"Laxative Polyethylene Glycol","slug":"laxative-polyethylene-glycol","indication":"Other","status":"marketed"},{"name":"Methylthioninium","genericName":"Methylthioninium","slug":"methylthioninium","indication":"Methemoglobinemia","status":"phase_3"},{"name":"Pegylated rhG-CSF regimen","genericName":"Pegylated rhG-CSF regimen","slug":"pegylated-rhg-csf-regimen","indication":"Chemotherapy-induced neutropenia (CIN)","status":"marketed"},{"name":"Pharmacotherapy","genericName":"Pharmacotherapy","slug":"pharmacotherapy","indication":"Other","status":"marketed"},{"name":"Polyethylene Glycol Recombinant Human Somatropin","genericName":"Polyethylene Glycol Recombinant Human Somatropin","slug":"polyethylene-glycol-recombinant-human-somatropin","indication":"Other","status":"phase_1"},{"name":"Probiotic Clostridium Butyricum","genericName":"Probiotic Clostridium Butyricum","slug":"probiotic-clostridium-butyricum","indication":"Other","status":"phase_1"},{"name":"Propofol,midazolam","genericName":"Propofol,midazolam","slug":"propofol-midazolam","indication":"Other","status":"marketed"},{"name":"Puyuanhewei","genericName":"Puyuanhewei","slug":"puyuanhewei","indication":"Other","status":"phase_1"},{"name":"R2-combination chemotherapy","genericName":"R2-combination chemotherapy","slug":"r2-combination-chemotherapy","indication":"Other","status":"marketed"},{"name":"Reference formulation of HRS-1893 tablet","genericName":"Reference formulation of HRS-1893 tablet","slug":"reference-formulation-of-hrs-1893-tablet","indication":"Other","status":"phase_1"},{"name":"Rulonilimab","genericName":"Rulonilimab","slug":"rulonilimab","indication":"Other","status":"phase_2"},{"name":"amoxicillin and furazolidone or amoxicillin and tetracycline","genericName":"amoxicillin and furazolidone or amoxicillin and tetracycline","slug":"amoxicillin-and-furazolidone-or-amoxicillin-and-tetracycline","indication":"Other","status":"marketed"},{"name":"esomeprazole, amoxicillin, furazolidone，tetracycline","genericName":"esomeprazole, amoxicillin, furazolidone，tetracycline","slug":"esomeprazole-amoxicillin-furazolidone-tetracycline","indication":"Other","status":"marketed"},{"name":"fluzoparil","genericName":"fluzoparil","slug":"fluzoparil","indication":"Other","status":"phase_2"},{"name":"salvage treatment for failed eradication","genericName":"salvage treatment for failed eradication","slug":"salvage-treatment-for-failed-eradication","indication":"Other","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":20,"colorKey":"immunology","drugs":[{"name":"AC-P,TEC,AC,TC,TCH,CEF,TAC,CAF","genericName":"AC-P,TEC,AC,TC,TCH,CEF,TAC,CAF","slug":"ac-p-tec-ac-tc-tch-cef-tac-caf","indication":"Cancer (specific indication not clearly defined from abbreviations alone)","status":"phase_3"},{"name":"Yangzhengxiaoji Capsule","genericName":"Yangzhengxiaoji Capsule","slug":"yangzhengxiaoji-capsule","indication":"Supportive care in cancer patients","status":"marketed"},{"name":"AC591","genericName":"AC591","slug":"ac591","indication":"Relapsed or refractory follicular lymphoma","status":"phase_2"},{"name":"Azacitidine combined HHT","genericName":"Azacitidine combined HHT","slug":"azacitidine-combined-hht","indication":"Acute myeloid leukemia (AML)","status":"phase_3"},{"name":"Consolidation Sintilimab","genericName":"Consolidation Sintilimab","slug":"consolidation-sintilimab","indication":"Consolidation therapy in non-small cell lung cancer (NSCLC) following concurrent chemoradiotherapy","status":"phase_3"},{"name":"Docetaxel or albumin paclitaxel","genericName":"Docetaxel or albumin paclitaxel","slug":"docetaxel-or-albumin-paclitaxel","indication":"Metastatic breast cancer","status":"marketed"},{"name":"Everolimus Tablets","genericName":"Everolimus Tablets","slug":"everolimus-tablets","indication":"Advanced renal cell carcinoma","status":"marketed"},{"name":"Fulvestrant injection ;Dalpiciclib Isethionate","genericName":"Fulvestrant injection ;Dalpiciclib Isethionate","slug":"fulvestrant-injection-dalpiciclib-isethionate","indication":"Hormone receptor-positive, HER2-negative advanced or metastatic breast cancer","status":"phase_3"},{"name":"H02+CHOP","genericName":"H02+CHOP","slug":"h02-chop","indication":"Lymphoma (likely non-Hodgkin lymphoma or Hodgkin lymphoma based on CHOP standard use)","status":"phase_3"},{"name":"HRS-8080 Tablet ; Dalpiciclib Isethionate","genericName":"HRS-8080 Tablet ; Dalpiciclib Isethionate","slug":"hrs-8080-tablet-dalpiciclib-isethionate","indication":"Hormone receptor-positive, HER2-negative breast cancer (in combination with endocrine therapy)","status":"phase_3"},{"name":"LY01008","genericName":"LY01008","slug":"ly01008","indication":"Non-small cell lung cancer","status":"phase_3"},{"name":"PD-1 combined with chemotherapy","genericName":"PD-1 combined with chemotherapy","slug":"pd-1-combined-with-chemotherapy","indication":"Advanced or metastatic solid tumors (specific indication dependent on the chemotherapy partner and clinical trial data)","status":"marketed"},{"name":"R-CHOP; R-DA-EPOCH; R-HD MTX","genericName":"R-CHOP; R-DA-EPOCH; R-HD MTX","slug":"r-chop-r-da-epoch-r-hd-mtx","indication":"B-cell non-Hodgkin lymphoma (various subtypes including diffuse large B-cell lymphoma)","status":"phase_3"},{"name":"R-combination chemotherapy","genericName":"R-combination chemotherapy","slug":"r-combination-chemotherapy","indication":"B-cell non-Hodgkin lymphoma","status":"marketed"},{"name":"Rituxan +CHOP","genericName":"Rituxan +CHOP","slug":"rituxan-chop","indication":"Non-Hodgkin's lymphoma","status":"phase_3"},{"name":"TAC,TC,TA,CAF,CEF","genericName":"TAC,TC,TA,CAF,CEF","slug":"tac-tc-ta-caf-cef","indication":"Breast cancer (likely primary indication based on TAC regimen use)","status":"phase_3"},{"name":"Tamoxifen Citrate Tablets","genericName":"Tamoxifen Citrate Tablets","slug":"tamoxifen-citrate-tablets","indication":"Adjuvant treatment of breast cancer","status":"phase_3"},{"name":"Umbilical cord blood","genericName":"Umbilical cord blood","slug":"umbilical-cord-blood","indication":"Treatment of various conditions, including blood disorders, autoimmune diseases, and certain types of cancer","status":"phase_3"},{"name":"chemoradiotherapy Cisplatin","genericName":"chemoradiotherapy Cisplatin","slug":"chemoradiotherapy-cisplatin","indication":"Non-small cell lung cancer, ovarian cancer, testicular cancer, bladder cancer, and other types of cancer","status":"phase_3"},{"name":"chemoradiotherapy Paclitaxel","genericName":"chemoradiotherapy Paclitaxel","slug":"chemoradiotherapy-paclitaxel","indication":"Non-small cell lung cancer","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"neuroscience","drugs":[{"name":"HRS-5346","genericName":"HRS-5346","slug":"hrs-5346","indication":"Type 2 diabetes","status":"phase_2"},{"name":"LXI-15028","genericName":"LXI-15028","slug":"lxi-15028","indication":"Type 2 diabetes","status":"phase_3"},{"name":"F027","genericName":"F027","slug":"f027","indication":"Type 2 diabetes","status":"phase_3"},{"name":"F520","genericName":"F520","slug":"f520","indication":"Type 2 diabetes","status":"phase_2"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Amoxicilli","genericName":"Amoxicilli","slug":"amoxicilli","indication":"Acute bacterial sinusitis","status":"marketed"},{"name":"EV71 (inoculation vaccine)","genericName":"EV71 (inoculation vaccine)","slug":"ev71-inoculation-vaccine","indication":"Prevention of Enterovirus 71 infection and hand, foot, and mouth disease (HFMD)","status":"marketed"},{"name":"Huazhi Rougan granule","genericName":"Huazhi Rougan granule","slug":"huazhi-rougan-granule","indication":"Liver support and hepatic function (traditional indication)","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"infectious","drugs":[{"name":"Rocaltrol","genericName":"Rocaltrol","slug":"rocaltrol","indication":"Hyperparathyroidism Secondary to Chronic Renal Failure","status":"marketed"},{"name":"Erzhi Tiangui Granule","genericName":"Erzhi Tiangui Granule","slug":"erzhi-tiangui-granule","indication":"Yin deficiency with heat symptoms (traditional indication)","status":"phase_3"}]}],"pipeline":[{"name":"Amoxicilli","genericName":"Amoxicilli","slug":"amoxicilli","phase":"marketed","mechanism":"5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2C","indications":["Acute bacterial sinusitis","Acute exacerbation of chronic bronchitis","Acute otitis media","Bacterial pneumonia","Bacterial urinary infection"],"catalyst":""},{"name":"AC-P,TEC,AC,TC,TCH,CEF,TAC,CAF","genericName":"AC-P,TEC,AC,TC,TCH,CEF,TAC,CAF","slug":"ac-p-tec-ac-tc-tch-cef-tac-caf","phase":"phase_3","mechanism":"This is a chemotherapy regimen combining multiple cytotoxic agents to treat cancer by damaging DNA and inhibiting cell division.","indications":["Cancer (specific indication not clearly defined from abbreviations alone)"],"catalyst":""},{"name":"EV71 (inoculation vaccine)","genericName":"EV71 (inoculation vaccine)","slug":"ev71-inoculation-vaccine","phase":"marketed","mechanism":"EV71 vaccine stimulates the immune system to produce antibodies and cellular immunity against Enterovirus 71, preventing infection and disease.","indications":["Prevention of Enterovirus 71 infection and hand, foot, and mouth disease (HFMD)"],"catalyst":""},{"name":"Esomeprazole sodium for injection","genericName":"Esomeprazole sodium for injection","slug":"esomeprazole-sodium-for-injection","phase":"phase_2","mechanism":"Inhibits the H+/K+ ATPase enzyme","indications":["Gastroesophageal reflux disease","Erosive esophagitis","Zollinger-Ellison syndrome"],"catalyst":""},{"name":"HRS-5346","genericName":"HRS-5346","slug":"hrs-5346","phase":"phase_2","mechanism":"HRS-5346 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"LXI-15028","genericName":"LXI-15028","slug":"lxi-15028","phase":"phase_3","mechanism":"LXI-15028 is a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"Rocaltrol","genericName":"Rocaltrol","slug":"rocaltrol","phase":"marketed","mechanism":"Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Vitamin D-binding protein","indications":["Hyperparathyroidism Secondary to Chronic Renal Failure","Hypocalcemia","Hypocalcemia from End-Stage Renal Disease with Dialysis","Hypoparathyroidism","Hypophosphatemia"],"catalyst":""},{"name":"Yangzhengxiaoji Capsule","genericName":"Yangzhengxiaoji Capsule","slug":"yangzhengxiaoji-capsule","phase":"marketed","mechanism":"Yangzhengxiaoji Capsule is a traditional Chinese medicine formulation designed to support immune function and promote recovery in cancer patients.","indications":["Supportive care in cancer patients","Cancer treatment-related side effect management"],"catalyst":""},{"name":"an extract of Cimicifuga Foetida L.","genericName":"an extract of Cimicifuga Foetida L.","slug":"an-extract-of-cimicifuga-foetida-l","phase":"marketed","mechanism":"An herbal extract from Cimicifuga foetida that modulates estrogen-related pathways and inflammatory responses, traditionally used to manage menopausal symptoms.","indications":["Menopausal symptoms (hot flashes, night sweats, mood disturbances)"],"catalyst":""},{"name":"mLDG","genericName":"mLDG","slug":"mldg","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AC591","genericName":"AC591","slug":"ac591","phase":"phase_2","mechanism":"AC591 is a small molecule inhibitor of the PI3K delta subunit.","indications":["Relapsed or refractory follicular lymphoma"],"catalyst":""},{"name":"Azacitidine combined HHT","genericName":"Azacitidine combined HHT","slug":"azacitidine-combined-hht","phase":"phase_3","mechanism":"Azacitidine inhibits DNA methyltransferase to reactivate silenced tumor suppressor genes, while HHT (homoharringtonine) inhibits protein synthesis to induce apoptosis in leukemic cells.","indications":["Acute myeloid leukemia (AML)","Myelodysplastic syndrome (MDS)"],"catalyst":""},{"name":"BA1106","genericName":"BA1106","slug":"ba1106","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"CM336 Injection","genericName":"CM336 Injection","slug":"cm336-injection","phase":"phase_3","mechanism":"CM336 is a monoclonal antibody that targets and inhibits a specific immune checkpoint or inflammatory pathway to enhance anti-tumor immunity or reduce pathological inflammation.","indications":[],"catalyst":""},{"name":"Caspogunfin","genericName":"Caspogunfin","slug":"caspogunfin","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Consolidation Sintilimab","genericName":"Consolidation Sintilimab","slug":"consolidation-sintilimab","phase":"phase_3","mechanism":"Sintilimab is a monoclonal antibody that blocks PD-1 on immune cells, allowing them to recognize and attack cancer cells.","indications":["Consolidation therapy in non-small cell lung cancer (NSCLC) following concurrent chemoradiotherapy"],"catalyst":""},{"name":"Docetaxel or albumin paclitaxel","genericName":"Docetaxel or albumin paclitaxel","slug":"docetaxel-or-albumin-paclitaxel","phase":"marketed","mechanism":"Docetaxel and albumin-bound paclitaxel are taxane chemotherapy agents that stabilize microtubules by binding to β-tubulin, preventing their depolymerization and causing cell cycle arrest and apoptosis.","indications":["Metastatic breast cancer","Non-small cell lung cancer","Ovarian cancer","Gastric cancer","Head and neck cancer"],"catalyst":""},{"name":"Erzhi Tiangui Granule","genericName":"Erzhi Tiangui Granule","slug":"erzhi-tiangui-granule","phase":"phase_3","mechanism":"Erzhi Tiangui Granule is a traditional Chinese medicine formulation that nourishes yin and clears heat to address deficiency-related conditions.","indications":["Yin deficiency with heat symptoms (traditional indication)","Immune support and inflammatory conditions (investigational)"],"catalyst":""},{"name":"Everolimus Tablets","genericName":"Everolimus Tablets","slug":"everolimus-tablets","phase":"marketed","mechanism":"Everolimus inhibits mTOR (mammalian target of rapamycin), a key protein kinase that regulates cell growth and proliferation.","indications":["Advanced renal cell carcinoma","Breast cancer (hormone receptor-positive, HER2-negative)","Pancreatic neuroendocrine tumors","Subependymal giant cell astrocytoma (SEGA)","Organ transplant rejection prevention"],"catalyst":""},{"name":"F027","genericName":"F027","slug":"f027","phase":"phase_3","mechanism":"F027 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"F520","genericName":"F520","slug":"f520","phase":"phase_2","mechanism":"F520 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"Fluvustat","genericName":"Fluvustat","slug":"fluvustat","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Fulvestrant injection ;Dalpiciclib Isethionate","genericName":"Fulvestrant injection ;Dalpiciclib Isethionate","slug":"fulvestrant-injection-dalpiciclib-isethionate","phase":"phase_3","mechanism":"This combination uses fulvestrant to block estrogen receptors in breast cancer cells while dalpiciclib inhibits cyclin-dependent kinases 4 and 6 to prevent cell cycle progression.","indications":["Hormone receptor-positive, HER2-negative advanced or metastatic breast cancer"],"catalyst":""},{"name":"Glycyrrhetinic Acid","genericName":"Glycyrrhetinic Acid","slug":"glycyrrhetinic-acid","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Gushen Antai Pill","genericName":"Gushen Antai Pill","slug":"gushen-antai-pill","phase":"marketed","mechanism":"Gushen Antai Pill is a traditional Chinese medicine formulation designed to tonify kidney qi and secure the fetus, primarily used to prevent miscarriage and support pregnancy.","indications":["Threatened abortion and recurrent miscarriage","Pregnancy support in patients with kidney qi deficiency"],"catalyst":""},{"name":"H02+CHOP","genericName":"H02+CHOP","slug":"h02-chop","phase":"phase_3","mechanism":"H02+CHOP is a chemotherapy combination regimen that uses doxorubicin, cyclophosphamide, vincristine, and prednisone to inhibit cancer cell proliferation and induce apoptosis.","indications":["Lymphoma (likely non-Hodgkin lymphoma or Hodgkin lymphoma based on CHOP standard use)"],"catalyst":""},{"name":"HRS-1780 Tablets","genericName":"HRS-1780 Tablets","slug":"hrs-1780-tablets","phase":"phase_3","mechanism":"HRS-1780 is an investigational small molecule with unknown mechanism of action in Phase 3 development.","indications":[],"catalyst":""},{"name":"HRS-1893 Tablets","genericName":"HRS-1893 Tablets","slug":"hrs-1893-tablets","phase":"phase_3","mechanism":"HRS-1893 is an investigational small molecule with unknown mechanism of action in Phase 3 development.","indications":[],"catalyst":""},{"name":"HRS-7085","genericName":"HRS-7085","slug":"hrs-7085","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"HRS-7535 Tablets","genericName":"HRS-7535 Tablets","slug":"hrs-7535-tablets","phase":"phase_3","mechanism":"HRS-7535 is an investigational small molecule with unknown mechanism of action in Phase 3 development.","indications":[],"catalyst":""},{"name":"HRS-7535 tablet","genericName":"HRS-7535 tablet","slug":"hrs-7535-tablet","phase":"phase_3","mechanism":"HRS-7535 tablet's mechanism of action is not publicly available.","indications":[],"catalyst":""},{"name":"HRS-8080 Tablet ; Dalpiciclib Isethionate","genericName":"HRS-8080 Tablet ; Dalpiciclib Isethionate","slug":"hrs-8080-tablet-dalpiciclib-isethionate","phase":"phase_3","mechanism":"Dalpiciclib is a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor that blocks cell cycle progression by preventing phosphorylation of the retinoblastoma protein.","indications":["Hormone receptor-positive, HER2-negative breast cancer (in combination with endocrine therapy)"],"catalyst":""},{"name":"HRS-8080 Tablets","genericName":"HRS-8080 Tablets","slug":"hrs-8080-tablets","phase":"phase_3","mechanism":"HRS-8080 is an investigational small molecule with unknown mechanism of action in Phase 3 development.","indications":[],"catalyst":""},{"name":"Henagliflozin 10mg","genericName":"Henagliflozin 10mg","slug":"henagliflozin-10mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Huazhi Rougan Granule Placebo granule","genericName":"Huazhi Rougan Granule Placebo granule","slug":"huazhi-rougan-granule-placebo-granule","phase":"marketed","mechanism":"This is a placebo granule formulation with no active pharmaceutical ingredient and therefore no mechanistic action.","indications":["Clinical trial control comparator (non-therapeutic use)"],"catalyst":""},{"name":"Huazhi Rougan granule","genericName":"Huazhi Rougan granule","slug":"huazhi-rougan-granule","phase":"marketed","mechanism":"Huazhi Rougan granule is a traditional Chinese medicine formulation designed to support liver function and promote hepatic health through its herbal constituents.","indications":["Liver support and hepatic function (traditional indication)"],"catalyst":""},{"name":"LY01008","genericName":"LY01008","slug":"ly01008","phase":"phase_3","mechanism":"LY01008 is a humanized monoclonal antibody that targets and inhibits PD-L1, blocking its interaction with PD-1 and B7.1 to enhance anti-tumor immune responses.","indications":["Non-small cell lung cancer","Other solid tumors (under investigation)"],"catalyst":""},{"name":"LY01015","genericName":"LY01015","slug":"ly01015","phase":"phase_3","mechanism":"LY01015 is a small molecule inhibitor that targets a specific molecular pathway involved in disease pathogenesis.","indications":[],"catalyst":""},{"name":"Laxative Polyethylene Glycol","genericName":"Laxative Polyethylene Glycol","slug":"laxative-polyethylene-glycol","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Methylthioninium","genericName":"Methylthioninium","slug":"methylthioninium","phase":"phase_3","mechanism":"Microtubule-associated protein tau, Amine oxidase [flavin-containing] A, Amine oxidase [flavin-containing] B","indications":["Methemoglobinemia"],"catalyst":""},{"name":"PD-1 combined with chemotherapy","genericName":"PD-1 combined with chemotherapy","slug":"pd-1-combined-with-chemotherapy","phase":"marketed","mechanism":"PD-1 inhibitor combined with chemotherapy blocks immune checkpoint PD-1 to restore anti-tumor T-cell activity while chemotherapy directly kills cancer cells.","indications":["Advanced or metastatic solid tumors (specific indication dependent on the chemotherapy partner and clinical trial data)"],"catalyst":""},{"name":"Pegylated rhG-CSF regimen","genericName":"Pegylated rhG-CSF regimen","slug":"pegylated-rhg-csf-regimen","phase":"marketed","mechanism":"Pegylated recombinant human granulocyte-colony stimulating factor (rhG-CSF) stimulates the proliferation and differentiation of neutrophil progenitor cells to increase circulating neutrophil counts.","indications":["Chemotherapy-induced neutropenia (CIN)","Severe congenital neutropenia","Idiopathic or cyclic neutropenia"],"catalyst":""},{"name":"Pharmacotherapy","genericName":"Pharmacotherapy","slug":"pharmacotherapy","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Polyethylene Glycol Recombinant Human Somatropin","genericName":"Polyethylene Glycol Recombinant Human Somatropin","slug":"polyethylene-glycol-recombinant-human-somatropin","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Probiotic Clostridium Butyricum","genericName":"Probiotic Clostridium Butyricum","slug":"probiotic-clostridium-butyricum","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Propofol,midazolam","genericName":"Propofol,midazolam","slug":"propofol-midazolam","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Puyuanhewei","genericName":"Puyuanhewei","slug":"puyuanhewei","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"R-CHOP; R-DA-EPOCH; R-HD MTX","genericName":"R-CHOP; R-DA-EPOCH; R-HD MTX","slug":"r-chop-r-da-epoch-r-hd-mtx","phase":"phase_3","mechanism":"R-CHOP, R-DA-EPOCH, and R-HD MTX are combination chemotherapy regimens that use rituximab (an anti-CD20 monoclonal antibody) combined with various cytotoxic chemotherapy agents to target and destroy B-cell lymphomas.","indications":["B-cell non-Hodgkin lymphoma (various subtypes including diffuse large B-cell lymphoma)","Primary CNS lymphoma (R-HD MTX regimen)"],"catalyst":""},{"name":"R-combination chemotherapy","genericName":"R-combination chemotherapy","slug":"r-combination-chemotherapy","phase":"marketed","mechanism":"R-combination chemotherapy uses rituximab (a monoclonal antibody targeting CD20) combined with cytotoxic chemotherapy agents to kill B-cell malignancies.","indications":["B-cell non-Hodgkin lymphoma","Diffuse large B-cell lymphoma (DLBCL)","Follicular lymphoma","Chronic lymphocytic leukemia (CLL)"],"catalyst":""},{"name":"R2-combination chemotherapy","genericName":"R2-combination chemotherapy","slug":"r2-combination-chemotherapy","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Reference formulation of HRS-1893 tablet","genericName":"Reference formulation of HRS-1893 tablet","slug":"reference-formulation-of-hrs-1893-tablet","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Rituxan +CHOP","genericName":"Rituxan +CHOP","slug":"rituxan-chop","phase":"phase_3","mechanism":"Rituxan is a monoclonal antibody that targets and depletes CD20-positive B cells, while CHOP is a chemotherapy regimen that includes cyclophosphamide, doxorubicin, vincristine, and prednisone.","indications":["Non-Hodgkin's lymphoma","Chronic lymphocytic leukemia"],"catalyst":""},{"name":"Rulonilimab","genericName":"Rulonilimab","slug":"rulonilimab","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"TAC,TC,TA,CAF,CEF","genericName":"TAC,TC,TA,CAF,CEF","slug":"tac-tc-ta-caf-cef","phase":"phase_3","mechanism":"TAC/TC/TA/CAF/CEF are chemotherapy regimens combining docetaxel, doxorubicin, and cyclophosphamide with or without fluorouracil and epirubicin for cancer treatment.","indications":["Breast cancer (likely primary indication based on TAC regimen use)","Other solid tumors (specific indications unknown)"],"catalyst":""},{"name":"Tamoxifen Citrate Tablets","genericName":"Tamoxifen Citrate Tablets","slug":"tamoxifen-citrate-tablets","phase":"phase_3","mechanism":"Tamoxifen Citrate Tablets work by competitively inhibiting estrogen receptors on tumor cells.","indications":["Adjuvant treatment of breast cancer","Treatment of metastatic breast cancer"],"catalyst":""},{"name":"Umbilical cord blood","genericName":"Umbilical cord blood","slug":"umbilical-cord-blood","phase":"phase_3","mechanism":"Umbilical cord blood contains stem cells that may aid in tissue repair and regeneration.","indications":["Treatment of various conditions, including blood disorders, autoimmune diseases, and certain types of cancer"],"catalyst":""},{"name":"amoxicillin and furazolidone or amoxicillin and tetracycline","genericName":"amoxicillin and furazolidone or amoxicillin and tetracycline","slug":"amoxicillin-and-furazolidone-or-amoxicillin-and-tetracycline","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"chemoradiotherapy Cisplatin","genericName":"chemoradiotherapy Cisplatin","slug":"chemoradiotherapy-cisplatin","phase":"phase_3","mechanism":"Cisplatin works by interfering with DNA replication, causing cell death in rapidly dividing cancer cells.","indications":["Non-small cell lung cancer, ovarian cancer, testicular cancer, bladder cancer, and other types of cancer","Head and neck cancer"],"catalyst":""},{"name":"chemoradiotherapy Paclitaxel","genericName":"chemoradiotherapy Paclitaxel","slug":"chemoradiotherapy-paclitaxel","phase":"phase_3","mechanism":"Paclitaxel works by inhibiting cell division, thereby preventing cancer cells from growing and dividing.","indications":["Non-small cell lung cancer","Ovarian cancer","Breast cancer","Pancreatic cancer"],"catalyst":""},{"name":"esomeprazole, amoxicillin, furazolidone，tetracycline","genericName":"esomeprazole, amoxicillin, furazolidone，tetracycline","slug":"esomeprazole-amoxicillin-furazolidone-tetracycline","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"fluzoparil","genericName":"fluzoparil","slug":"fluzoparil","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"salvage treatment for failed eradication","genericName":"salvage treatment for failed eradication","slug":"salvage-treatment-for-failed-eradication","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":62,"phaseCounts":{"marketed":22,"phase_3":25,"phase_2":9,"phase_1":6},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}